BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10341365)

  • 21. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure.
    Hirota H; Izumi M; Hamaguchi T; Sugiyama S; Murakami E; Kunisada K; Fujio Y; Oshima Y; Nakaoka Y; Yamauchi-Takihara K
    Heart Vessels; 2004 Sep; 19(5):237-41. PubMed ID: 15372299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple levels of regulation of the interleukin-6 system in stroke.
    Acalovschi D; Wiest T; Hartmann M; Farahmi M; Mansmann U; Auffarth GU; Grau AJ; Green FR; Grond-Ginsbach C; Schwaninger M
    Stroke; 2003 Aug; 34(8):1864-9. PubMed ID: 12843357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130.
    Yasukawa K; Futatsugi K; Saito T; Yawata H; Narazaki M; Suzuki H; Taga T; Kishimoto T
    Immunol Lett; 1992 Feb; 31(2):123-30. PubMed ID: 1740350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
    Weiss TW; Arnesen H; Seljeflot I
    Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
    Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes.
    Song C; Kenis G; van Gastel A; Bosmans E; Lin A; de Jong R; Neels H; Scharpé S; Janca A; Yasukawa K; Maes M
    Psychiatry Res; 1999 Mar; 85(3):293-303. PubMed ID: 10333381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.
    Wonnerth A; Katsaros KM; Krychtiuk KA; Speidl WS; Kaun C; Thaler K; Huber K; Wojta J; Maurer G; Seljeflot I; Arnesen H; Weiss TW
    Metabolism; 2014 May; 63(5):647-53. PubMed ID: 24629561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble gp130, an antagonist of IL-6 transsignaling, is elevated in uveitis aqueous humor.
    Simon D; Denniston AK; Tomlins PJ; Wallace GR; Rauz S; Salmon M; Murray PI; Curnow SJ
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3988-91. PubMed ID: 18469182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.
    Abrahamsen B; Bonnevie-Nielsen V; Ebbesen EN; Gram J; Beck-Nielsen H
    J Bone Miner Res; 2000 Aug; 15(8):1545-54. PubMed ID: 10934653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia.
    Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
    Neurotox Res; 2018 Feb; 33(2):448-460. PubMed ID: 29103192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Soluble IL-6 receptors].
    Jabłońska E
    Postepy Hig Med Dosw; 1998; 52(2):133-8. PubMed ID: 9640977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
    Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V
    Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo immunomodulatory effects of clozapine in schizophrenia.
    Maes M; Bosmans E; Kenis G; De Jong R; Smith RS; Meltzer HY
    Schizophr Res; 1997 Aug; 26(2-3):221-5. PubMed ID: 9323354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
    Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
    Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological differences between patients with major depression and somatization syndrome.
    Rief W; Pilger F; Ihle D; Bosmans E; Egyed B; Maes M
    Psychiatry Res; 2001 Dec; 105(3):165-74. PubMed ID: 11814536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.
    Lin A; Kenis G; Bignotti S; Tura GJ; De Jong R; Bosmans E; Pioli R; Altamura C; Scharpé S; Maes M
    Schizophr Res; 1998 Jun; 32(1):9-15. PubMed ID: 9690329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseases.
    Doré P; Lelièvre E; Morel F; Brizard A; Fourcin M; Clemént C; Ingrand P; Daneski L; Gascan H; Wijdenes J; Gombert J; Preud'homme JL; Lecron JC
    Clin Exp Immunol; 1997 Jan; 107(1):182-8. PubMed ID: 9010274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD.
    Memoli B; Grandaliano G; Soccio M; Postiglione L; Guida B; Bisesti V; Esposito P; Procino A; Marrone D; Michael A; Andreucci M; Schena FP; Pertosa G
    J Am Soc Nephrol; 2005 Apr; 16(4):1099-107. PubMed ID: 15716332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.